
Privacy notice | Accessibility statement | Terms and conditions | Login | Contact |
UK data driving real-world evidence
Bibliography
Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,700 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 6 April 2021) and papers are listed below and in the PDF below.
If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.
Download:
(PDF, 5MB, 226 pages)This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website.
“Acute liver injury associated with nonsteroidal anti-inflammatory drugs and the role of risk factors”, Arch Intern Med, vol. 154, pp. 311-6, 1994.
, “Antidepressant drugs and suicide”, J Clin Psychopharmacol, vol. 12, pp. 235-40, 1992.
, “Antidepressants and convulsions”, J Clin Psychopharmacol, vol. 12, pp. 241-5, 1992.
, “Antidepressants and suicide”, Bmj, vol. 310, pp. 215-8, 1995.
, “Cholestatic hepatitis associated with flucloxacillin”, Med J Aust, vol. 158, pp. 596-600, 1993.
, “A comparison of the risk of hypoglycemia between users of human and animal insulins. 1. Experience in the United Kingdom”, Pharmacotherapy, vol. 10, pp. 395-7, 1990.
, “Erythromycin-associated cholestatic hepatitis”, Med J Aust, vol. 158, pp. 600-2, 1993.
, “Flucloxacillin and cholestatic hepatitis”, Med J Aust, vol. 160, p. 525, 1994.
, “A follow-up safety study of ciprofloxacin users”, Pharmacotherapy, vol. 13, pp. 461-4, 1993.
, “Liver disease associated with diclofenac, naproxen, and piroxicam”, Pharmacotherapy, vol. 12, pp. 207-12, 1992.
, “Liver disorders in patients receiving chlorpromazine or isoniazid”, Pharmacotherapy, vol. 13, pp. 353-8, 1993.
, “Nonsteroidal antiinflammatory drugs and certain rare, serious adverse events: a cohort study”, Pharmacotherapy, vol. 13, pp. 212-7, 1993.
, “The risk of sulfasalazine- and mesalazine-associated blood disorders”, Pharmacotherapy, vol. 15, pp. 176-81, 1995.
, “Urinary tract infections and estrogen use in older women”, J Am Geriatr Soc, vol. 40, pp. 817-20, 1992.
,